CellaVision AB (publ) (LON:0MR5)

London flag London · Delayed Price · Currency is GBP · Price in SEK
180.30
+0.90 (0.50%)
At close: Oct 15, 2025
0.50%
Market Cap345.16M
Revenue (ttm)57.68M
Net Income (ttm)11.60M
Shares Outn/a
EPS (ttm)0.49
PE Ratio29.74
Forward PE24.63
Dividend0.20 (0.11%)
Ex-Dividend DateMay 7, 2025
Volumen/a
Average Volume27
Openn/a
Previous Close179.40
Day's Rangen/a
52-Week Range148.32 - 288.84
Beta1.24
RSI53.77
Earnings DateNov 6, 2025

About CellaVision AB

CellaVision AB (publ) develops and sells instruments, software, and reagents for blood and body fluids analysis in Sweden and internationally. The company provides digital hematology microscopy solutions, covering analyzers and instruments; and hardware products, including in vitro diagnostics IVD for laboratories; smear makers, stainers, stains, and staining protocols; DIFF-Line, a hematology lab that handles a smaller amount daily blood samples, as well as consists of three instruments, such as CellaVision DC-1, RAL SmearBox, and RAL StainBox... [Read more]

Industry Electromedical and Electrotherapeutic Apparatus
Founded 1994
Employees 219
Stock Exchange London Stock Exchange
Ticker Symbol 0MR5
Full Company Profile

Financial Performance

In 2024, CellaVision AB's revenue was 723.22 million, an increase of 6.78% compared to the previous year's 677.29 million. Earnings were 140.72 million, an increase of 7.99%.

Financial numbers in SEK Financial Statements

News

There is no news available yet.